Not a good buy right now: trend is still bearish (SMA_200 > SMA_20 > SMA_5) and momentum remains negative despite being oversold.
With no Intellectia buy signals today, there’s no high-conviction “buy now” trigger for an impatient entry.
Options market is pricing a large move (very high IV), but there’s no clear news catalyst this week—risk/reward for a spot buy is unfavorable.
If you must act immediately, this is better treated as an avoid/exit until price reclaims the pivot (~6.39) and holds above it.
Technical Analysis
Trend: Bearish structure with moving averages stacked down (SMA_200 > SMA_20 > SMA_5), indicating persistent downtrend.
Momentum: MACD histogram -0.0663 (below 0) but negatively contracting → downside momentum is fading, not reversed.
RSI: RSI_6 = 25.97 → effectively oversold/washed-out conditions; bounce potential exists, but oversold alone is not a buy signal in a downtrend.
Levels: Support S1 ~5.96 (near current price), then S2 ~5.70. Resistance at pivot ~6.39, then R1 ~6.81.
Pattern-based odds: model suggests modest upside bias over 1W–1M (2.28% next week; 7.78% next month), but near-term edge is not strong enough to override the current downtrend.
Positioning (Open Interest): Put/Call OI ratio = 0.18 → call-heavy positioning, generally bullish/less hedged.
Flow (Volume): Put/Call volume ratio = 1.0 → neutral day’s flow (puts and calls balanced by volume).
Volatility: 30D IV = 82.34 vs HV = 36.04; IV percentile = 97.61 → options are very expensive, market pricing a large move.
Activity: Today’s volume (20) is far below recent 5D/10D averages (161.6/95.3), but “today vs avg 30D” is elevated (43.48) → still not broad participation.
Takeaway: Sentiment via OI leans bullish, but extremely high IV without a clear catalyst makes buying shares “now” less attractive (market expects turbulence; edge is unclear).
Technical Summary
Sell
9
Buy
4
Positive Catalysts
can fuel short-covering or a reflex bounce.
Neutral/Negative Catalysts
Primary trend remains bearish (MA stack down), so rallies are more likely to be sold until structure improves.
Profitability deterioration in the latest quarter: net income -72% YoY, EPS -75% YoY, gross margin down ~6.7% YoY.
Options IV is extremely elevated (97th percentile) despite no news this week—implies uncertainty/event-risk that isn’t clearly identified.
No supportive “smart money” confirmation: hedge funds neutral; insiders neutral; no notable recent accumulation signal.
Financial Performance
Latest quarter: 2026/Q3.
Revenue: 219.07M, +9.16% YoY (growth is intact).
Net income: 2.90M, -72.22% YoY (sharp profitability decline).
EPS: 0.01, -75.00% YoY.
Gross margin: 66.41%, -6.71% YoY (margin compression is a key negative trend).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent analyst activity (Citi only in provided data): maintained Neutral; price target moved from $9 → $8 (2025-11-24) then raised $8 → $9 (2025-12-08).
Net message from Wall Street (based on provided notes): not a high-conviction bullish stance—more of a “wait and see” view with limited catalyst-driven urgency.
Pros view: acknowledges potential upside to ~$9 vs $6.05 if execution stabilizes.
Cons view: Neutral rating suggests uncertainty around fundamentals/trajectory—consistent with the recent margin and earnings pressure.
Wall Street analysts forecast CXM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CXM is 9.4 USD with a low forecast of 7 USD and a high forecast of 12 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast CXM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CXM is 9.4 USD with a low forecast of 7 USD and a high forecast of 12 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
4 Hold
1 Sell
Hold
Current: 5.950
Low
7
Averages
9.4
High
12
Current: 5.950
Low
7
Averages
9.4
High
12
Citi
Neutral
maintain
$8 -> $9
AI Analysis
2025-12-08
Reason
Citi
Price Target
$8 -> $9
AI Analysis
2025-12-08
maintain
Neutral
Reason
Citi raised the firm's price target on Sprinklr to $9 from $8 and keeps a Neutral rating on the shares.
Citi
Neutral
downgrade
$9 -> $8
2025-11-24
Reason
Citi
Price Target
$9 -> $8
2025-11-24
downgrade
Neutral
Reason
Citi lowered the firm's price target on Sprinklr to $8 from $9 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CXM
